Skip to main content
Lorenzo Falchi, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

LorenzoFalchiMD

Oncology • New York, NY

Hematologic Oncology

Assistant Attending Physician

Request Appointment

Overview of Dr. Falchi

Dr. Lorenzo Falchi is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from University of Perugia Faculty of Medicine and has been in practice since 2005. He also speaks multiple languages, including Italian. He specializes in hematologic oncology and is experienced in non-hodgkin lymphoma and immunotherapy.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2019
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia , 2012 - 2013
  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer CenterLeukemia , 2011 - 2012
  • University of Perugia
    University of PerugiaSpecialist, Cum Laude, 2005 - 2009
  • University of Perugia Faculty of Medicine
    University of Perugia Faculty of MedicineClass of 2005

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 2016 - 2026
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • ECFMGECFMG Certificate

Awards, Honors, & Recognition

  • Future Leaders in Hematology Celgene, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AbbVie, Genmab's Lymphoma Drug Epkinly Snags FDA Approval in Heated Blood Cancer Race
    AbbVie, Genmab's Lymphoma Drug Epkinly Snags FDA Approval in Heated Blood Cancer RaceMay 19th, 2023
  • 'Remarkable' Study Shows Potential of Chemotherapy-Free Regimen for Follicular Lymphoma
    'Remarkable' Study Shows Potential of Chemotherapy-Free Regimen for Follicular LymphomaDecember 13th, 2023

Committees

  • Member, Society for immunotherapy of cancer - Early Career Scientists 2016 - Present

Professional Memberships

Other Languages

  • Italian

Hospital Affiliations

Dr. Lorenzo Falchi, Dr. Lorenzo Falchi, MD, Dr. L Falchi